Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients (CGRCard)
Impact de la Transfusion de Culots Globulaires de Moins de 14 Jours Sur la Morbi-mortalité Chez Des Patients en Chirurgie Cardiaque
Sponsor: Centre Hospitalier Universitaire de Besancon
Terminated
Retrospective study from December 2007 to May 2010
Other terminated trials from Centre Hospitalier Universitaire de Besancon
- Metastatic Colorectal Cancer · Phase PHASE2 · Nov 2024
- Gallstone · Phase NA · Sep 2024
- Children, Only · Phase NA · Apr 2024
- Mandibular Dysfunction · Phase NA · Feb 2024
- Metastatic Pancreatic Adenocarcinoma · Phase PHASE2 · Feb 2024
See all terminations from Centre Hospitalier Universitaire de Besancon
A observational or N/A phase clinical study on Postoperative; Dysfunction Following Cardiac Surgery and Transfusion Related Complication, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Universitaire de Besancon and has accumulated 6 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Besancon
For direct contact, visit the study record on ClinicalTrials.gov .